Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





p-TOLUIDINE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 106-49-0; **Chemical Formula:** CH3C6H4NH2
OSHA had no former PEL for p-toluidine. OSHA proposed establishing a 2-ppm PEL, with a skin notation, and these limits are established in the final rule. The ACGIH considers this substance a suspected human carcinogen and has given it a classification of A2 (ACGIH 1986/Ex. 1-3). p-Toluidine is a white solid.
One study investigates the carcinogenic potential of lifetime exposure to p-toluidine in experimental animals (Weisburger, Russfield, Homburger et al. 1978/Ex. 1-535). Male and female mice were exposed to p-toluidine in the diet for a total of 18 months. During the first six months of the experiment, mice were exposed to 1000 or 2000 mg p-toluidine/kg diet. As a result of the weight loss that occurred in mice exposed to the 2000 mg/kg diet dose, the concentrations of p-toluidine were reduced to 500 and 1000 mg/kg diet during the last 12 months of exposure. The rate of food consumption by the animals was not reported and was assumed to be 3 g/day. Thus, the average doses of p-toluidine received during the 18-month exposure were calculated to be 80 and 160 mg/kg body weight per day (Weisburger, Russfield, Homburger et al. 1978/Ex. 1-535).
For both the low and high dietary doses of p-toluidine, a significant increase in the incidence of hepatomas was observed. The incidence of tumors in the control, 80, and 160 mg/kg/day groups were 3/38, 10/38, and 12/35, respectively. The same study (Weisburger, Russfield, Homburger et al. 1978/Ex. 1-535) showed negative results in male rats exposed to two doses of p-toluidine in the diet for 18 months (1000- and 2000-mg/kg diet).
Risk estimate for p-toluidine. To assess the quantitative risk of p-toluidine’s carcinogenicity, OSHA used the Weisburger et al. (1978/Ex. 1-535) data which, despite some limitations (e.g., changes in dose levels during the experiment and the absence of data concerning the amount of food animals consumed during the exposure period), were considered adequate for risk assessment purposes.
The maximum likelihood estimates (MLE) of excess cancers per 1,000 workers over an occupational lifetime and the 95-percent upper-bound estimates were obtained by using a linearized multistage model (GLOBAL83). These values are summarized in Table C15-8. This table shows the number of cancer deaths potentially associated with working lifetime exposure to 20, 5, or 2 ppm p-toluidine.
OSHA concludes, as Table C15-8 shows, that workers exposed to p-toluidine, which was formerly not regulated by OSHA, are at significant risk of developing hepatomas; an effect that the Agency considers a material impairment of health. For example, the MLE at 20 ppm is 112 excess cancer deaths per 1,000 workers exposed over a working lifetime. Promulgating a PEL of 2 ppm will substantially reduce this significant risk. According to this scenario, a 90-percent reduction in excess cancer deaths will be achieved by establishing the 2-ppm limit. The risks existing at the former uncontrolled level are clearly significant. NIOSH (Ex. 8-47, Table N6B) judged the evidence on p-toluidine sufficient to warrant a separate 6(b) rulemaking. OSHA is establishing an 8-hour TWA limit of 2 ppm for p-toluidine in the final rule; a skin notation is included to protect against percutaneous absorption of this substance.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue